5 Value Stocks In The Healthcare Sector
5 Value Stocks In The Healthcare Sector
What is a Value Stock?
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
The following stocks are considered to be notable value stocks in the healthcare sector:
- Spok Holdings (NASDAQ:SPOK) - P/E: 8.96
- MEI Pharma (NASDAQ:MEIP) - P/E: 1.53
- Roivant Sciences (NASDAQ:ROIV) - P/E: 2.17
- Agile Therapeutics (NASDAQ:AGRX) - P/E: 0.17
- Exicure (NASDAQ:XCUR) - P/E: 0.34
Most recently, Spok Holdings reported earnings per share at $0.22, whereas in Q2 earnings per share sat at $0.23. The company's most recent dividend yield sits at 8.6%, which has decreased by 2.22% from 10.82% last quarter.
MEI Pharma's earnings per share for Q2 sits at $-1.66, whereas in Q1, they were at 8.46. Roivant Sciences saw an increase in earnings per share from -0.4 in Q2 to $-0.21 now. Agile Therapeutics saw an increase in earnings per share from -3.1 in Q2 to $-1.47 now. This quarter, Exicure experienced an increase in earnings per share, which was $-0.7 in Q1 and is now $-0.68.
The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.
What is a Value Stock?
什麼是價值股？
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
傳統上，價值股是根據市場上投資者如何估值該公司的未來增長前景來定義的。低市盈率倍數是表明公司被低估的良好基礎指標，很可能被貼上價值股的標籤。
The following stocks are considered to be notable value stocks in the healthcare sector:
以下股票被認爲是醫療保健領域值得注意的價值股票：
- Spok Holdings (NASDAQ:SPOK) - P/E: 8.96
- MEI Pharma (NASDAQ:MEIP) - P/E: 1.53
- Roivant Sciences (NASDAQ:ROIV) - P/E: 2.17
- Agile Therapeutics (NASDAQ:AGRX) - P/E: 0.17
- Exicure (NASDAQ:XCUR) - P/E: 0.34
- Spok Holdings（納斯達克股票代碼：SPOK）——市盈率：8.96
- MEI Pharma（納斯達克股票代碼：MEIP）——市盈率：1.53
- Roivant Sciences（納斯達克股票代碼：ROIV）——市盈率：2.17
- Agile Therapeutics（納斯達克股票代碼：AGRX）——市盈率：0.17
- Exicure（納斯達克股票代碼：XCUR）——市盈率：0.34
Most recently, Spok Holdings reported earnings per share at $0.22, whereas in Q2 earnings per share sat at $0.23. The company's most recent dividend yield sits at 8.6%, which has decreased by 2.22% from 10.82% last quarter.
最近，Spok Holdings公佈的每股收益爲0.22美元，而第二季度的每股收益爲0.23美元。該公司最近的股息收益率爲8.6％，較上個季度的10.82％下降了2.22％。
MEI Pharma's earnings per share for Q2 sits at $-1.66, whereas in Q1, they were at 8.46. Roivant Sciences saw an increase in earnings per share from -0.4 in Q2 to $-0.21 now. Agile Therapeutics saw an increase in earnings per share from -3.1 in Q2 to $-1.47 now. This quarter, Exicure experienced an increase in earnings per share, which was $-0.7 in Q1 and is now $-0.68.
MEI Pharma第二季度的每股收益爲-1.66美元，而第一季度的每股收益爲8.46美元。Roivant Sciences的每股收益從第二季度的-0.4美元增長到現在的-0.21美元。Agile Therapeutics的每股收益從第二季度的-3.1美元增長到現在的-1.47美元。本季度，Exicure的每股收益有所增加，第一季度爲-0.7美元，目前爲-0.68美元。
The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.
意義：價值股可能需要一些時間才能從其被低估的位置中反彈。投資價值股的風險在於，這種出現可能永遠無法實現。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧